LIMK2 Use of LIMK2 to predict prognosis in renal cancer patients

摘要

The present invention relates to the use of LIMK2 for predicting the prognosis for renal cancer and a formulation for preventing or treating renal cancer comprising a LIMK2 inhibitor. provides a biomarker for prognosing the prognosis for kidney cancer, and LIMK2 inhibitor LIMK2 protein expression inhibitor, or LIMK2 mRNA expression inhibitor, LIMK2 protein expression, cell survival, colony formation and cell migration of cells of renal cancer cells By confirming the inhibitory activity, a composition comprising a LIMK2 inhibitor as an active ingredient is provided as a formulation for the prevention, improvement and treatment of renal cancer.